Literature DB >> 32319376

[Immunophenotypic Analysis of Patients with Adult Acute T-Lymphoblastic Leukemia].

Na Lin1, Zheng-Hua Liu1, Ping-Ping Wang1, Wei Fu1, Xiao-Jing Yan1, Yan Li2.   

Abstract

OBJECTIVE: To analyze the results of immunophenotyping in patients with acute T-lymphoblastic leukemia (T-ALL) so as to improve the understanding of early T-cell precursor acute T-lymphoblastic leukemia (ETP-ALL) and near ETP-ALL with elevated CD5.
METHODS: The results of immunophenotypes in 62 patients with newly diagnosed adult T-ALL in our hospital were retrospectively analyzed. According to the expression of CD5, CD1a, CD8 and My/S antigens, the patients were divided into 3 groups: ETP, near ETP and non-ETP. The immunophenotypic characteristics and basic clinical data of three groups were compared and analyzed.
RESULTS: There were significant differences in age, white blood cell and plt counts as well as percentage of bone marrow blasts among three groups (P<0.05). ETP and near ETP mainly belonged to Pro T and pre T, and non-ETP mainly belonged to cortical T and mature T. The positive rates of My/S, CD1a, CD8 and CD5 were significantly different among three groups (P<0.01). The positive rates of CD4 and CD3 in non-ETP group were significantly higher than those in ETP and near-ETP group (P<0.01). The positive rate of CD56 in near-ETP group was 50%, which was significantly higher than that in ETP group (16.7%) and non-ETP group (0%) (P<0.01).
CONCLUSION: According to the expression of CD5, CD1a, CD8 and My/S antigens, T-ALL patients can be divided into three groups: ETP, near ETP and non ETP, the immunophenotypes and basic clinical data among 3 groups are statistically different.

Entities:  

Mesh:

Year:  2020        PMID: 32319376     DOI: 10.19746/j.cnki.issn.1009-2137.2020.02.014

Source DB:  PubMed          Journal:  Zhongguo Shi Yan Xue Ye Xue Za Zhi        ISSN: 1009-2137


  1 in total

1.  Relevance of flow cytometric categorization and end-of-induction measurable residual disease assessment in pediatric and adult T-lymphoblastic leukemia patients.

Authors:  Karthik Bommannan; Jhansi Rani Arumugam; Venkatraman Radhakrishnan; Jayachandran Perumal Kalaiyarasi; Parathan Karunakaran; Nikita Mehra; Tenali Gnana Sagar; Shirley Sundersingh
Journal:  Blood Res       Date:  2022-07-27
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.